Science Review Examines Coordinated Neuromodulator Activity During Sleep
Recent research shows several brain chemicals rise and fall together while people sleep. A new review in Science discusses possible links between this coordination and health outcomes.
link.springer.comRecent studies have documented simultaneous changes in five neuromodulators during sleep. The chemicals norepinephrine, serotonin, acetylcholine, dopamine, and histamine show synchronized oscillations rather than independent patterns. A Science review published this week examines what these coordinated fluctuations may mean for physiological processes.
The article surveys existing data on timing relationships among the five substances.
The review focuses on measurements taken during different sleep stages. Researchers recorded activity across multiple brain regions in both human and animal subjects. Prior work had examined each neuromodulator separately. The new synthesis highlights periods when all five substances move in phase.
The review outlines several areas where synchronized neuromodulator activity could relate to health. These include memory processing, emotional regulation, and metabolic functions. The authors note that further experiments are needed to test causal relationships. No clinical recommendations are included in the current review.
Key Facts
Story Timeline
2 events- This week
Science publishes review on synchronized neuromodulator activity during sleep.
1 source@ScienceMagazine - Recent period
Multiple studies record coordinated changes in norepinephrine, serotonin, acetylcholine, dopamine, and histamine.
1 source@ScienceMagazine
Potential Impact
- 01
Future experiments may test whether coordinated neuromodulator activity affects memory formation.
- 02
Additional studies could examine links between these patterns and metabolic regulation.
Transparency Panel
Related Stories
NprWHO Director Visits Congo as Ebola Outbreak Spreads
The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.
medpagetoday.comFDA Panel Recommends XFG Variant for Fall Covid Shots
Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.
Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery
Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…